Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Ohio’s Yes on Issue 2: U.S. Consumers Pay $84,000 for a Drug Egyptians Buy for $83!!

Ohio Taxpayers for Lower Drug Prices
Posted on: 20 Sep 17

Sovaldi, the hepatitis C wonder drug, sells for $84,000 in the U.S. but for only $83 in Egypt, says the British tabloid the Daily Mail. The newspaper also reports Egyptian entrepreneurs are providing round-trip air fare to Egypt, a five day tour of the countryside and a Sovaldi cure for $7,000 to foreigners.

In 2014, Gilead Sciences agreed to make Sovaldi available for about $900 per treatment to Egypt. Whether it’s $83 or $900, U.S. consumers and taxpayers are heavily subsidizing the treatment of hundreds of thousands of hepatitis C sufferers in Egypt while in the U.S. Sovaldi’s price tag has forced Medicaid and private insurers to ration the drug, making it available only to persons in the final stages of the potentially deadly liver disease.

Source: Daily Mail and Reuters.

Background on Ohio Ballot Issue 2

The Yes on Issue 2 campaign is a broad-based, bi-partisan coalition. More than 200,000 Ohio voters signed petitions to put an amendment on the ballot in November that will lower drug prices for over 4 million Ohioans, including 164,000 children, save taxpayers $400 million annually, reduce healthcare costs for everyone and teach greedy drug companies and their CEOs a lesson.

You can learn more by visiting or following us on Facebook and Twitter.

Paid for by Ohio Taxpayers for Lower Drug Prices

View source version on

Business Wire

Last updated on: 20/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.